Digital Health Market Size, Share, Forecast, & Trends Analysis by Component (Hardware, Services, Software), Technology (Telehealth, mHealth, DTx), Application (Cardiovascular, Primary Care, Respiratory)

Description

List of Tables

Digital Health Market Size, Share, Forecast, & Trends Analysis by Component (Hardware, Services, Software), Technology (Telehealth, mHealth [Apps, Monitoring Devices], DTx), Application (Cardiovascular, Primary Care, Respiratory) - Global Forecast to 2031

The digital health market is expected to reach $1,338.52 billion by 2031, at a CAGR of 20.4% from 2024 to 2031.

Following thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, opportunities, and trends.

The growth of this market is driven by the increasing access to smartphones and the internet in developing economies, the rising adoption of fitness apps, the increasing use of mHealth and digital therapeutics, the growing adoption of wearable medical devices, and the increasing focus on preventive healthcare. Moreover, the focus on developing advanced medical technologies, the shift toward intelligent health ecosystems, and the growing adoption of remote patient monitoring and home healthcare are expected to generate growth opportunities for the players operating in the digital health market.

Based on component, the digital health market is segmented into hardware, software, and services. In 2024, the services segment is expected to account for the largest share of 63.5% of the digital health market. This segment's large market share is attributed to the adoption of telehealth services, the growing demand for remote patient monitoring, the growth in telemedicine, and the rising prevalence of chronic diseases.

Based on technology, the digital health market is segmented into telehealth, mHealth, digital therapeutics, and digital health systems. The digital therapeutics segment is expected to grow at the highest CAGR of 31.5% during the forecast period. The growth of this segment is attributed to the rising prevalence of chronic diseases, growing focus on preventative healthcare and self-testing, growing access and penetration of digital technologies in developing countries, including rural areas, and increasing investments in the digital therapeutics industry.

Furthermore, market players' strategies, such as expanding their presence, diversifying product portfolios, and launching new products, further support the segment's growth. For instance, in January 2023, Teladoc Health Inc. (U.S.) launched its digital application for individualized whole-person care. The app enables consumers to access Teladoc Health's full range of services, including primary care, mental health, and chronic condition management, from one place and under a single portable account.

Based on application, the digital health market is segmented into telehealth applications, mHealth applications, digital therapeutics applications, and digital health system applications. The digital therapeutics applications segment is expected to grow at the highest CAGR during the forecast period 2024 to 2031. This growth of the segment is driven by the rising prevalence of chronic diseases, increasing focus on preventive healthcare, and rising concerns over healthcare expenditure. Digital therapeutics help patients prevent disease onset via clinically verified preventive care. Major market players and governments worldwide are increasingly prioritizing investments, policies, and initiatives that promote preventive healthcare. For instance, in March 2021, the European Commission launched the EU4Health program for the period of 2021-2027, with an investment of $6.03 billion (€5.1 billion) in the healthcare sector for disease prevention, health promotion, digital transformation of the healthcare system, integration of digital services & tools, and other areas of intervention.

Based on end user, the digital health market is segmented into providers, individual consumers, employers, payers, and other end users. The individual consumers segment is expected to record the highest CAGR during the forecast period. The growth of this segment is driven by the rising awareness regarding personal health in developing countries and high awareness in developed countries, the growing availability of health management solutions, increasing digitalization in healthcare, the growing adoption of wearable medical devices, including health monitoring devices and fitness trackers, the rising prevalence of chronic diseases and the emergence of telehealth.

The growing mobile health industry is impacting the expansion of telehealth and telemedicine among general populations. Patients have started using technology to monitor and track their health due to the increased availability of consumer-friendly mobile health apps and innovative mobile medical equipment. Patients can gather their medical information for diagnosis without having to go to the doctor's office using simple home-use medical devices that can record vitals, identify ear infections, monitor glucose levels, or measure blood pressure.

An in-depth analysis of the geographical scenario of the digital health market provides detailed qualitative and quantitative insights into five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the global digital health market, followed by Europe and Asia-Pacific. However, the market in Asia-Pacific is slated to register the highest CAGR of 23.2% during the forecast period. The growth of this regional market is driven by favorable government initiatives for digitalization, growing healthcare expenditure, growing internet and smartphone penetration in rural areas, the shortage of healthcare professionals, and growing awareness regarding digital health technologies.

Key companies operating in the global digital health market are ResMed Inc. (U.S.), Teladoc Health, Inc. (U.S.), Noom, Inc. (U.S.), Aerotel Medical Systems (1998) Ltd. (Israel), Cerner Corporation (U.S.) (a subsidiary of Oracle Corporation), Medtronic plc (U.K.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Cisco Systems, Inc. (U.S.), Johnson and Johnson (U.S.), Allscripts Healthcare, LLC (U.S.), Omron Healthcare Inc. (Japan), GE Healthcare (U.S.), Abbott Laboratories (U.S.), International Business Machines Corporation (U.S.), and Samsung Electronics Co. Ltd. (South Korea).

Scope of the Report:

Digital Health Market Assessment-by Component

Hardware
- Wearable Devices
- Non-wearable Devices
Software
- Subscription-based
- Licensing-based
Services
- Subscription-based
- Pay Per Service-based

Digital Health Market Assessment-by Technology

mHealth
- mHealth Apps
Disease Management & Treatment Apps
Women's Health Apps
Clinical & Diagnostic Apps
Mental Health Apps
Chronic Disease Management Apps
Medication Management Apps
Sleep Monitoring Apps
Other Disease Management & Treatment Apps
Wellness Apps
Diet & Nutrition Apps
Fitness & Workout Apps
Other mHealth Apps

(Note: Other mHealth apps include insurance & claims processing apps and medical data management apps.)

mHealth Monitoring Devices

Vital Sign Monitoring Devices
Heart Rate Monitors
Activity Monitors
Electrocardiographs
Pulse Oximeters
Spirometers
Blood Pressure Monitors
Blood Glucose Monitors
Sleep Monitoring Devices
Fetal Electrocardiographs & Obstetric Devices
Neuromonitoring Devices
Electroencephalographs
Electromyographs
Other mHealth Monitoring Devices

(Note: Other mHealth monitoring devices include peak flow meters and multiparameter trackers.)

Telehealth
- Hardware
Activity Monitoring
Blood Glucose Monitors
Blood Pressure Monitors
Weighing Scales
Pulse Oximeters
Peak Flow Meters
ECG Monitors
Patient Monitors
Other Activity Monitoring Devices

(Note: Other activity monitoring devices include digital thermometers, coagulation monitors, pacemakers, Implantable Cardioverter Defibrillators (ICD), Cardiac Resynchronization Therapy (CRT) devices, and stethoscopes.)

Telemedicine Kiosks
Telemedicine Carts
Remote Medication Management Devices
- Software & Services
RPM
Video Consultation
Store & Forward
Digital Therapeutics
- Disease Management & Treatment DTx
- Disease Prevention DTx
Digital Health Systems
- EHR
- E-prescribing Systems
- Healthcare Analytics
- Other Digital Health Systems

(Note: Other digital health systems include health information management systems and Clinical Decision Support Systems (CDSS), among others.)

Digital Health Market Assessment-by Application

Telehealth Applications
- Psychiatry
- Radiology
- Cardiology
- Primary Care
- Dermatology
- Remote ICU
- Other Telehealth Applications

(Note: Other telehealth applications include nutrition, nursing, pharmacy, dentistry, audiology, neurology, rehabilitation, pathology, and surgery.)

mHealth Applications
- Cardiology
- Diabetes
- Respiratory Conditions
- Neurology
- Other mHealth Applications

(Note: Other mHealth applications include fitness, medication management, and rehabilitation.)

Digital Therapeutics Applications
- Mental Health
- Diabetes
- Cardiovascular Diseases
- Gastrointestinal Disorders
- Neurology
- Rehabilitation & Patient Care
- Oncology
- Respiratory Disorders
- Addiction Management
- Sleep Disorders
- Smoking Cessation
- Other Digital Therapeutics Applications

(Note: Other digital therapeutics applications include medication adherence, eye & ear diseases, dermatology, infectious & parasitic diseases, and genitourinary diseases.)

Digital Health System Applications
- Practice Management
- Population Health Management
Population Health Analytics
Patient Portals
- Computerized Physician Order Entry (CPOE)
- Clinical Decision Support (CDS)
- Clinical Analytics
- Financial Analytics
- Other Digital Health System Applications

(Note: Other digital health system applications include operational & administrative analytics, clinical management, and referral management.)

Digital Health Market Assessment-by End User

Providers
Individual Consumers
Employers
Payers
- Public Payers
- Private/Out-of-pocket Payers
Other End Users

(Note: Other end users include pharmaceutical organizations and government institutes.)

Digital Health Market Assessment-by Geography

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe (RoE)
Asia-Pacific (APAC)
- Japan
- China
- India
- Rest of Asia-Pacific (RoAPAC)
Latin America
Middle East & Africa

Product Code: MRHC - 1041215

1. Overview

1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Data Collection & Validation Process
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing & Forecasting
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
- 2.3.3. Market Share Analysis
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

4.1. Overview
4.2. Factors Affecting Market Growth
- 4.2.1. Market Dynamics
  - 4.2.1.1. Drivers
    - 4.2.1.1.1. Increasing Internet & Smartphone Penetration
    - 4.2.1.1.2. Growing Adoption of Fitness Apps
    - 4.2.1.1.3. Rising Adoption of mHealth & Digital Therapeutics
    - 4.2.1.1.4. Increasing Focus on Preventive Healthcare
    - 4.2.1.1.5. Rising Adoption of Wearable Medical Devices
  - 4.2.1.2. Restraints
    - 4.2.1.2.1. Data Security & Privacy Concerns
    - 4.2.1.2.2. High Cost of Deployment
  - 4.2.1.3. Opportunities
    - 4.2.1.3.1. Focus on Developing Advanced Medical Technologies
    - 4.2.1.3.2. Shift Toward Intelligent Health Ecosystems
    - 4.2.1.3.3. Growing Adoption of Remote Patient Monitoring & Home Healthcare
  - 4.2.1.4. Challenges
    - 4.2.1.4.1. Lack of Common Standards & Regulatory Frameworks
    - 4.2.1.4.2. Technological Barriers in Emerging Economies
4.3. Trends
- 4.3.1. Integration of Artificial Intelligence (AI) and Machine Learning (ML) into Healthcare
- 4.3.2. Use of IoT Technology in Medical Devices
- 4.3.3. Development of Telerobots
4.4. Factors Analysis
4.5. Porter's Five Forces Analysis
4.6. Investment & Funding Analysis
4.7. Reimbursement Scenario
4.8. Case Studies

5. Digital Health Market Assessment-by Component

5.1. Overview
5.2. Hardware
- 5.2.1. Wearable Devices
- 5.2.2. Non-wearable Devices
5.3. Software
- 5.3.1. Subscription-based
- 5.3.2. Licensing-based
5.4. Services
- 5.4.1. Subscription-based
- 5.4.2. Pay Per Service-based

6. Digital Health Market Assessment-by Technology

6.1. Overview
6.2. mHealth
- 6.2.1. mHealth Apps
  - 6.2.1.1. Disease Management & Treatment Apps
    - 6.2.1.1.1. Women's Health Apps
    - 6.2.1.1.2. Clinical & Diagnostic Apps
    - 6.2.1.1.3. Mental Health Apps
    - 6.2.1.1.4. Chronic Disease Management Apps
    - 6.2.1.1.5. Medication Management Apps
    - 6.2.1.1.6. Sleep Monitoring Apps
    - 6.2.1.1.7. Other Disease Management & Treatment Apps
  - 6.2.1.2. Wellness Apps
    - 6.2.1.2.1. Diet & Nutrition Apps
    - 6.2.1.2.2. Fitness & Workout Apps
  - 6.2.1.3. Other mHealth Apps
- 6.2.2. mHealth Monitoring Devices
  - 6.2.2.1. Vital Sign Monitoring Devices
    - 6.2.2.1.1. Heart Rate Monitors
    - 6.2.2.1.2. Activity Monitors
    - 6.2.2.1.3. Electrocardiographs
    - 6.2.2.1.4. Pulse Oximeters
    - 6.2.2.1.5. Spirometers
    - 6.2.2.1.6. Blood Pressure Monitors
    - 6.2.2.1.7. Blood Glucose Monitors
  - 6.2.2.2. Sleep Monitoring Devices
  - 6.2.2.3. Fetal Electrocardiographs & Obstetric Devices
  - 6.2.2.4. Neuromonitoring Devices
    - 6.2.2.4.1. Electroencephalographs
    - 6.2.2.4.2. Electromyographs
  - 6.2.2.5. Other mHealth Monitoring Devices
6.3. Telehealth
- 6.3.1. Hardware
  - 6.3.1.1. Activity Monitoring
    - 6.3.1.1.1. Blood Glucose Monitors
    - 6.3.1.1.2. Blood Pressure Monitors
    - 6.3.1.1.3. Weighing Scales
    - 6.3.1.1.4. Pulse Oximeters
    - 6.3.1.1.5. Peak Flow Meters
    - 6.3.1.1.6. ECG Monitors
    - 6.3.1.1.7. Patient Monitors
    - 6.3.1.1.8. Other Activity Monitoring Devices
  - 6.3.1.2. Telemedicine Kiosks
  - 6.3.1.3. Telemedicine Carts
  - 6.3.1.4. Remote Medication Management Devices
- 6.3.2. Software & Services
  - 6.3.2.1. RPM
  - 6.3.2.2. Video Consultation
  - 6.3.2.3. Store & Forward
6.4. Digital Therapeutics
- 6.4.1. Disease Management & Treatment DTx
- 6.4.2. Disease Prevention DTx
6.5. Digital Health Systems
- 6.5.1. EHR
- 6.5.2. E-prescribing Systems
- 6.5.3. Healthcare Analytics
- 6.5.4. Other Digital Health Systems

7. Digital Health Market Assessment-by Application

7.1. Overview
7.2. Telehealth Applications
- 7.2.1. Psychiatry
- 7.2.2. Radiology
- 7.2.3. Cardiology
- 7.2.4. Primary Care
- 7.2.5. Dermatology
- 7.2.6. Remote ICU
- 7.2.7. Other Telehealth Applications
7.3. mHealth Applications
- 7.3.1. Cardiology
- 7.3.2. Diabetes
- 7.3.3. Respiratory Conditions
- 7.3.4. Neurology
- 7.3.5. Other mHealth Applications
7.4. Digital Therapeutics Applications
- 7.4.1. Mental Health
- 7.4.2. Diabetes
- 7.4.3. Cardiovascular Diseases
- 7.4.4. Gastrointestinal Disorders
- 7.4.5. Neurology
- 7.4.6. Rehabilitation & Patient Care
- 7.4.7. Oncology
- 7.4.8. Respiratory Disorders
- 7.4.9. Addiction Management
- 7.4.10. Sleep Disorders
- 7.4.11. Smoking Cessation
- 7.4.12. Other Digital Therapeutics Applications
7.5. Digital Health System Applications
- 7.5.1. Practice Management
- 7.5.2. Population Health Management
  - 7.5.2.1. Population Health Analytics
  - 7.5.2.2. Patient Portals
- 7.5.3. Computerized Physician Order Entry (CPOE)
- 7.5.4. Clinical Decision Support (CDS)
- 7.5.5. Clinical Analytics
- 7.5.6. Financial Analytics
- 7.5.7. Other Digital Health System Applications

8. Digital Health Market Assessment-by End User

8.1. Overview
8.2. Providers
8.3. Individual Consumers
8.4. Employers
8.5. Payers
- 8.5.1. Public Payers
- 8.5.2. Private/Out-of-pocket Payers
8.6. Other End Users

9. Digital Health Market Assessment-by Geography

9.1. Overview
9.2. North America
- 9.2.1. U.S.
- 9.2.2. Canada
9.3. Europe
- 9.3.1. Germany
- 9.3.2. France
- 9.3.3. U.K.
- 9.3.4. Italy
- 9.3.5. Spain
- 9.3.6. Rest of Europe
9.4. Asia-Pacific
- 9.4.1. China
- 9.4.2. India
- 9.4.3. Japan
- 9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East & Africa

10. Competition Analysis

10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
- 10.4.1. Industry Leaders
- 10.4.2. Market Differentiators
- 10.4.3. Vanguards
- 10.4.4. Emerging Companies
10.5. Market Share Analysis/Market Rankings of Key Players (2023)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

11.1. ResMed Inc.
11.2. Teladoc Health, Inc.
11.3. Noom, Inc.
11.4. Aerotel Medical Systems (1998) Ltd.
11.5. Cerner Corporation (A Subsidiary of Oracle Corporation)
11.6. Medtronic Plc
11.7. Koninklijke Philips N.V.
11.8. Siemens Healthineers AG
11.9. Cisco Systems, Inc.
11.10. Johnson and Johnson
11.11. Allscripts Healthcare, LLC
11.12. Omron Healthcare Inc.
11.13. GE Healthcare
11.14. Abbott Laboratories
11.15. International Business Machines Corporation
11.16. Samsung Electronics Co. Ltd.

(Note: SWOT analysis will be provided for the top 5 companies.)

12. Appendix

12.1. Available Customization
12.2. Related Reports